Judith Carolina De Arcos-Jiménez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Judith Carolina De Arcos-Jiménez has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Jaime Briseno-Ramirez
Centro Universitario de Tlajomulco, Universidad de Guadalajara
23 shared publications - Pedro Martínez-Ayala
HIV Unit, Hospital Civil de Guadalajara “Fray Antonio Alcalde”, Guadalajara 44280, Mexico
11 shared publications - Ana María López-Yáñez
División Salud, Centro Universitario de Tlajomulco, Universidad de Guadalajara, Tlajomulco de Zúñiga, Jalisco, Mexico
9 shared publications - Roberto Miguel Damian-Negrete
División Salud, Centro Universitario de Tlajomulco, Universidad de Guadalajara, Tlajomulco de Zuñiga 45641, Mexico
9 shared publications - Adolfo Gómez-Quiroz
Microbiology Laboratory, Hospital Civil de Guadalajara “Fray Antonio Alcalde”, Guadalajara 44280, Mexico
5 shared publications - Oscar Francisco Fernández-Diaz
Universidad de Guadalajara, Centro Universitario de Tlajomulco, Tlajomulco de Zuñiga, Mexico
5 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by Springer Nature in BMC Health Services Research
Assessing Mexico’s prison health system: access, care processes, resources, accountability and administrative mortality indicators
Background: Mexico lacks a national assessment integrating chronic-care pathways in prisons with prison resources, supervision and administrative indicators. We assessed these domains across complementary national public sources. Methods: We performed a secondary analysis of public observational data. Cross-sectional ENPOL 2021 microdata classified chronic-care episodes by provider and financing. Independent ENSANUT 2021 samples provided age-sex-standardized treatment benchmarks, including socioeconomically restricted comparators. A mixed model specified with a directed acyclic graph related state prison occupancy to unattended care with a documented barrier, adjusting for marginalization, system size, pretrial share, legal status and incarceration duration. Repeated aggregate administrative series (CNSIPEE 2021–2025; monthly PRS reports 2015–2026) were analyzed ecologically, not as individual follow-up. Results: Among 10,280 chronic-care episodes, 53.9% (95% CI 52.9–55.0) were center-provided, 20.8% (19.9–21.7) self/family-financed and 23.1% (22.1–24.0) untreated. Among untreated non-communicable episodes in state prisons, center non-provision was the most frequent reason for absent treatment. In 6,301 people across 32 states, higher occupancy was associated with unattended care (aOR per state SD 1.37, 95% CI 1.12–1.66; survey-weighted 1.37, 1.12–1.67), and greater prison medical staffing with less unattended care (aOR 0.75, 0.63–0.89); there was no clear evidence of an association with general-system medical capacity. Untreated diabetes exceeded ENSANUT 2021 estimates by 11.55 percentage points (7.46–15.65), and this gap persisted when the comparator was restricted to lower-socioeconomic strata, whereas the initial hypertension difference (13.60 points) was not clearly demonstrated in the lowest-wellbeing tercile. Indigenous identification was associated with 3.6 points (1.2–6.0) more unattended care within states. Periodic medical review was reported by 41.8%. Service-availability contrasts were inconclusive, and administrative mortality series did not support time-ordered inference. Conclusion: Ongoing chronic care in Mexican prisons relied substantially on family financing or remained untreated, and higher occupancy and lower medical staffing were consistently associated with unattended care. Administrative indicators should be read as monitoring signals; prospective center-level data with stable identifiers are needed.
- 23 October 2026
- Published by Springer Nature in BMC Health Services Research
Open AccessAssessing Mexico’s prison health system: access, care processes, resources, accountability and administrative mortality indicators
Background: Mexico lacks a national assessment integrating chronic-care pathways in prisons with prison resources, supervision and administrative indicators. We assessed these domains across complementary national public sources. Methods: We performed a secondary analysis of public observational data. Cross-sectional ENPOL 2021 microdata classified chronic-care episodes by provider and financing. Independent ENSANUT 2021 samples provided age-sex-standardized treatment benchmarks, including socioeconomically restricted comparators. A mixed model specified with a directed acyclic graph related state prison occupancy to unattended care with a documented barrier, adjusting for marginalization, system size, pretrial share, legal status and incarceration duration. Repeated aggregate administrative series (CNSIPEE 2021–2025; monthly PRS reports 2015–2026) were analyzed ecologically, not as individual follow-up. Results: Among 10,280 chronic-care episodes, 53.9% (95% CI 52.9–55.0) were center-provided, 20.8% (19.9–21.7) self/family-financed and 23.1% (22.1–24.0) untreated. Among untreated non-communicable episodes in state prisons, center non-provision was the most frequent reason for absent treatment. In 6,301 people across 32 states, higher occupancy was associated with unattended care (aOR per state SD 1.37, 95% CI 1.12–1.66; survey-weighted 1.37, 1.12–1.67), and greater prison medical staffing with less unattended care (aOR 0.75, 0.63–0.89); there was no clear evidence of an association with general-system medical capacity. Untreated diabetes exceeded ENSANUT 2021 estimates by 11.55 percentage points (7.46–15.65), and this gap persisted when the comparator was restricted to lower-socioeconomic strata, whereas the initial hypertension difference (13.60 points) was not clearly demonstrated in the lowest-wellbeing tercile. Indigenous identification was associated with 3.6 points (1.2–6.0) more unattended care within states. Periodic medical review was reported by 41.8%. Service-availability contrasts were inconclusive, and administrative mortality series did not support time-ordered inference. Conclusion: Ongoing chronic care in Mexican prisons relied substantially on family financing or remained untreated, and higher occupancy and lower medical staffing were consistently associated with unattended care. Administrative indicators should be read as monitoring signals; prospective center-level data with stable identifiers are needed.
- Open Access
- 22 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8209
Constant Versus Ascending Radial Pressure Wave Therapy for Pain Management in Carpal Tunnel Syndrome: A Pilot Exploratory Study
Background/Objectives: This exploratory report compares two radial pressure wave therapy (RPWT) regimens for carpal tunnel syndrome and describes clinical trajectories and observations relevant to future trial design. The statistical plan and the selection of the 2-month comparison followed inspection of the study data. Methods: Fifty-one participants were randomized (25 constant, 26 ascending; NCT07070661). Seven left the study (six ascending, one constant); forty-three contributed clinical scores. Both arms received three weekly sessions and the same home exercise program; pressure, frequency, and theoretical emission duration differed jointly. The main exploratory comparison was between-regimen pain change at 2 months. Results: The pain difference (ascending minus constant) was points on the numeric pain rating scale (NPRS, 0–10; 95% CI to ), and observed mean NPRS decreased from baseline to 2 months in both arms: from 6.50 to 4.04 in the constant arm and from 6.37 to 3.37 in the ascending arm. Descriptive observations included asymmetric attrition (six of seven departures in the ascending arm) and observed baseline imbalance (grip strength SMD 0.624; symptom duration 28.7 versus 39.2 months). Three participants had early indications for carpal tunnel release. Conclusions: Although mean pain improved in both groups, these non-conclusive pilot data establish neither superiority nor equivalence. The observed improvement cannot be attributed to the RPWT device because both groups received exercises and no sham or exercise-only control was included. These findings inform a definitive trial with stratified randomization and an appropriate comparator.- 22 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8209
Open AccessConstant Versus Ascending Radial Pressure Wave Therapy for Pain Management in Carpal Tunnel Syndrome: A Pilot Exploratory Study
Background/Objectives: This exploratory report compares two radial pressure wave therapy (RPWT) regimens for carpal tunnel syndrome and describes clinical trajectories and observations relevant to future trial design. The statistical plan and the selection of the 2-month comparison followed inspection of the study data. Methods: Fifty-one participants were randomized (25 constant, 26 ascending; NCT07070661). Seven left the study (six ascending, one constant); forty-three contributed clinical scores. Both arms received three weekly sessions and the same home exercise program; pressure, frequency, and theoretical emission duration differed jointly. The main exploratory comparison was between-regimen pain change at 2 months. Results: The pain difference (ascending minus constant) was points on the numeric pain rating scale (NPRS, 0–10; 95% CI to ), and observed mean NPRS decreased from baseline to 2 months in both arms: from 6.50 to 4.04 in the constant arm and from 6.37 to 3.37 in the ascending arm. Descriptive observations included asymmetric attrition (six of seven departures in the ascending arm) and observed baseline imbalance (grip strength SMD 0.624; symptom duration 28.7 versus 39.2 months). Three participants had early indications for carpal tunnel release. Conclusions: Although mean pain improved in both groups, these non-conclusive pilot data establish neither superiority nor equivalence. The observed improvement cannot be attributed to the RPWT device because both groups received exercises and no sham or exercise-only control was included. These findings inform a definitive trial with stratified randomization and an appropriate comparator. - Open Access
- 12 September 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (5) , 566
Time-Zero Kidney Biopsy and Deceased-Donor Transplant Outcomes: A Systematic Review and Meta-Analysis of Prognostic Value, Prediction, and Clinical Utility
Background/Objectives: Time-zero biopsy informs deceased-donor kidney implantation or discard, but its prognostic value is contested. We systematically reviewed pre-reperfusion morphological biopsy evidence in adult deceased-donor kidney transplantation, keeping four questions separate: prognostic association, incremental prediction, clinical utility and measurement reproducibility. Methods: We searched PubMed/MEDLINE, Embase, Scopus, Web of Science, CENTRAL and three trial registries through 25 July 2026 without date or language restriction. One estimate per non-overlapping cohort was selected under a prespecified hierarchy; random-effects models used restricted maximum likelihood with Hartung–Knapp inference; GRADE assessed certainty. Results: Of 45,676 records, 25,746 were screened; 203 eligible reports (159 study investigations and 154 cohort families) and 22 contextual reports were included. Vascular injury was associated with delayed graft function (odds ratio: 1.85, 95% CI 1.11–3.06), glomerulosclerosis with graft failure (hazard ratio: 2.03, 1.22–3.39) and vascular injury with graft failure (hazard ratio: 1.48, 1.07–2.04); glomerulosclerosis with delayed graft function was inconclusive (odds ratio: 1.13, 0.59–2.17). All 12 pooled bodies were of very low certainty. Conclusions: Current evidence does not support time-zero histology as a stand-alone rule for accepting or discarding a deceased-donor kidney. Whether standardized histology adds predictive information beyond established clinical variables remains open and should be addressed in linked registry analyses before biopsy findings guide management.
- 12 September 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (5) , 566
Open AccessTime-Zero Kidney Biopsy and Deceased-Donor Transplant Outcomes: A Systematic Review and Meta-Analysis of Prognostic Value, Prediction, and Clinical Utility
Background/Objectives: Time-zero biopsy informs deceased-donor kidney implantation or discard, but its prognostic value is contested. We systematically reviewed pre-reperfusion morphological biopsy evidence in adult deceased-donor kidney transplantation, keeping four questions separate: prognostic association, incremental prediction, clinical utility and measurement reproducibility. Methods: We searched PubMed/MEDLINE, Embase, Scopus, Web of Science, CENTRAL and three trial registries through 25 July 2026 without date or language restriction. One estimate per non-overlapping cohort was selected under a prespecified hierarchy; random-effects models used restricted maximum likelihood with Hartung–Knapp inference; GRADE assessed certainty. Results: Of 45,676 records, 25,746 were screened; 203 eligible reports (159 study investigations and 154 cohort families) and 22 contextual reports were included. Vascular injury was associated with delayed graft function (odds ratio: 1.85, 95% CI 1.11–3.06), glomerulosclerosis with graft failure (hazard ratio: 2.03, 1.22–3.39) and vascular injury with graft failure (hazard ratio: 1.48, 1.07–2.04); glomerulosclerosis with delayed graft function was inconclusive (odds ratio: 1.13, 0.59–2.17). All 12 pooled bodies were of very low certainty. Conclusions: Current evidence does not support time-zero histology as a stand-alone rule for accepting or discarding a deceased-donor kidney. Whether standardized histology adds predictive information beyond established clinical variables remains open and should be addressed in linked registry analyses before biopsy findings guide management.
- Open Access
- 4 August 2026
- Published by SAGE Publications in Therapeutic Advances in Infectious Disease
- Vol. 13
Adjunctive corticosteroids in non-HIV immunocompromised patients with Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis
Background: Pneumocystis jirovecii pneumonia (PJP) in non-HIV immunocompromised adults carries 30%–60% mortality. Adjunctive corticosteroids are standard in HIV-PJP but remain contested in non-HIV PJP. Objectives: To determine whether adjunctive corticosteroids reduce mortality and invasive mechanical ventilation (IMV) in non-HIV PJP, and whether effect estimates differ between randomized and observational study designs. Design: Systematic review and meta-analysis. Data sources and methods: Six databases and two trial registers were searched from inception to February 7, 2026. Randomized and observational studies comparing adjunctive corticosteroids versus no corticosteroids or placebo in non-HIV adults with PJP were eligible. Random-effects meta-analyses (restricted maximum likelihood) of two co-primary outcomes included subgroup, sensitivity, E -value, and Grading of Recommendations Assessment analyses. Results: Twenty-eight studies were included (one randomized controlled trial (RCT), 27 observational; ∼ 5300 patients): 22 contributed corticosteroid-versus-no-corticosteroid comparisons and six contributed dose-comparison data only. Evidence was discordant by design (interaction p = 0 . 006 ): the RCT showed lower IMV (hazard ratio (HR) 0.36, 95% CI 0.14–0.90) and lower 90-day mortality (HR 0.59, 0.37–0.93); regression-adjusted observational studies suggested harm (odds ratio (OR) 1.56, 1.10–2.22); propensity-based estimates were null-compatible. Pre-specified mortality pools were non-significant short-term (OR 1.22, 0.88–1.70) and intermediate-term (OR 1.39, 0.85–2.29). Secondary infections ( k = 4 ): OR 1.04 (0.63–1.72); RCT 0.59 (0.32–1.06). E -values for RCT effects (3.44 IMV; 2.24 mortality) exceeded the 1.81 E -value of the adjusted observational mortality pool. Certainty was very low for pooled mortality and moderate for RCT outcomes. Conclusion: Reliable inference rests on the single RCT rather than the pooled observational estimate, which is discordant by design and most consistent with confounding by indication. In the RCT, corticosteroids did not significantly reduce 28-day mortality but lowered IMV and 90-day mortality and sped respiratory recovery, without clear excess secondary infections (low certainty). Corticosteroids may be considered for severe respiratory failure using the PIC (ClinicalTrials.gov NCT02944045) protocol; adequately powered confirmatory trials are needed. Trial registration : PROSPERO CRD420261304396.
- 4 August 2026
- Published by SAGE Publications in Therapeutic Advances in Infectious Disease
- Vol. 13
Open AccessAdjunctive corticosteroids in non-HIV immunocompromised patients with Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis
Background: Pneumocystis jirovecii pneumonia (PJP) in non-HIV immunocompromised adults carries 30%–60% mortality. Adjunctive corticosteroids are standard in HIV-PJP but remain contested in non-HIV PJP. Objectives: To determine whether adjunctive corticosteroids reduce mortality and invasive mechanical ventilation (IMV) in non-HIV PJP, and whether effect estimates differ between randomized and observational study designs. Design: Systematic review and meta-analysis. Data sources and methods: Six databases and two trial registers were searched from inception to February 7, 2026. Randomized and observational studies comparing adjunctive corticosteroids versus no corticosteroids or placebo in non-HIV adults with PJP were eligible. Random-effects meta-analyses (restricted maximum likelihood) of two co-primary outcomes included subgroup, sensitivity, E -value, and Grading of Recommendations Assessment analyses. Results: Twenty-eight studies were included (one randomized controlled trial (RCT), 27 observational; ∼ 5300 patients): 22 contributed corticosteroid-versus-no-corticosteroid comparisons and six contributed dose-comparison data only. Evidence was discordant by design (interaction p = 0 . 006 ): the RCT showed lower IMV (hazard ratio (HR) 0.36, 95% CI 0.14–0.90) and lower 90-day mortality (HR 0.59, 0.37–0.93); regression-adjusted observational studies suggested harm (odds ratio (OR) 1.56, 1.10–2.22); propensity-based estimates were null-compatible. Pre-specified mortality pools were non-significant short-term (OR 1.22, 0.88–1.70) and intermediate-term (OR 1.39, 0.85–2.29). Secondary infections ( k = 4 ): OR 1.04 (0.63–1.72); RCT 0.59 (0.32–1.06). E -values for RCT effects (3.44 IMV; 2.24 mortality) exceeded the 1.81 E -value of the adjusted observational mortality pool. Certainty was very low for pooled mortality and moderate for RCT outcomes. Conclusion: Reliable inference rests on the single RCT rather than the pooled observational estimate, which is discordant by design and most consistent with confounding by indication. In the RCT, corticosteroids did not significantly reduce 28-day mortality but lowered IMV and 90-day mortality and sped respiratory recovery, without clear excess secondary infections (low certainty). Corticosteroids may be considered for severe respiratory failure using the PIC (ClinicalTrials.gov NCT02944045) protocol; adequately powered confirmatory trials are needed. Trial registration : PROSPERO CRD420261304396.
- Open Access
- 7 July 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (7) , e0094826
Whole-genome sequencing of Staphylococcus aureus isolates after a decade-long decline in MRSA prevalence at a university referral hospital in Guadalajara, Mexico: clonal concentration in MRSA and greater genetic diversity in MSSA
Methicillin-resistant Staphylococcus aureus (MRSA) prevalence has declined in many settings, but genomic features of residual MRSA populations remain incompletely defined. We performed whole-genome sequencing (WGS) of 26 S. aureus clinical isolates (13 MRSA and 13 methicillin-susceptible S. aureus [MSSA]) collected by stratified random sampling during 2024–2025. Analyses included de novo assembly, species confirmation, MLST/ spa /SCC mec typing, resistance and virulence profiling, mobile-element analysis, genotype–phenotype concordance, and recombination-filtered/contextual phylogenomics. A secondary matched case-control analysis explored clinical correlates. MRSA was concentrated in ST5-t895-SCC mec II (CC5, New York/Japan lineage; 9/13, 69.2%), whereas MSSA was diverse (11 sequence types and 9 clonal complexes; Simpson’s 1 − D = 0.974 vs 0.500). SA023 (CC5-MSSA, ST5-t688) nested within the MRSA-CC5 clade and lacked SCC mec , a pattern consistent with putative SCC mec excision. WGS resolved lineage-specific resistance and mobile-element architectures: CC5-MRSA carried SCC mec II with ermA / aadD and quinolone resistance-determining region mutations, while SCC mec IV MRSA belonged to CC8/CC88 and lacked arginine catabolic mobile element/copper and mercury resistance. Panton–Valentine leukocidin genes occurred in six isolates (four community-associated MRSA and two community-associated MSSA). WGS-based resistance prediction showed 91.7% categorical agreement with phenotypes. In the exploratory clinical analysis, prior antibiotic exposure, intensive care unit admission, and healthcare exposure score were associated with MRSA. Contemporary MRSA in this hospital is clonally concentrated, while MSSA is diverse. WGS identifies lineage-specific resistance and mobile element architectures, as well as one observation consistent with SCC mec excision, generating hypotheses for longitudinal surveillance rather than establishing a mechanism for MRSA decline. Clinical associations are secondary and exploratory. IMPORTANCE: Methicillin-resistant Staphylococcus aureus (MRSA) infections have declined in many hospitals, but cross-sectional clinical data alone cannot explain the genomic structure of the MRSA populations that remain. This study uses whole-genome sequencing to show that contemporary MRSA isolates from a Mexican university referral hospital are concentrated in a CC5 New York/Japan lineage, whereas methicillin-susceptible S. aureus (MSSA) isolates are genetically diverse. The analysis identifies lineage-specific resistance determinants, mobile genetic elements, prophage content, defense systems, and one CC5-MSSA isolate showing a pattern consistent with SCC mec excision. These findings provide a descriptive genomic baseline for longitudinal MRSA surveillance. The clinical risk-factor analysis is included as exploratory context, not as the primary evidence for the genomic conclusions.
- 7 July 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (7) , e0094826
Open AccessWhole-genome sequencing of Staphylococcus aureus isolates after a decade-long decline in MRSA prevalence at a university referral hospital in Guadalajara, Mexico: clonal concentration in MRSA and greater genetic diversity in MSSA
Methicillin-resistant Staphylococcus aureus (MRSA) prevalence has declined in many settings, but genomic features of residual MRSA populations remain incompletely defined. We performed whole-genome sequencing (WGS) of 26 S. aureus clinical isolates (13 MRSA and 13 methicillin-susceptible S. aureus [MSSA]) collected by stratified random sampling during 2024–2025. Analyses included de novo assembly, species confirmation, MLST/ spa /SCC mec typing, resistance and virulence profiling, mobile-element analysis, genotype–phenotype concordance, and recombination-filtered/contextual phylogenomics. A secondary matched case-control analysis explored clinical correlates. MRSA was concentrated in ST5-t895-SCC mec II (CC5, New York/Japan lineage; 9/13, 69.2%), whereas MSSA was diverse (11 sequence types and 9 clonal complexes; Simpson’s 1 − D = 0.974 vs 0.500). SA023 (CC5-MSSA, ST5-t688) nested within the MRSA-CC5 clade and lacked SCC mec , a pattern consistent with putative SCC mec excision. WGS resolved lineage-specific resistance and mobile-element architectures: CC5-MRSA carried SCC mec II with ermA / aadD and quinolone resistance-determining region mutations, while SCC mec IV MRSA belonged to CC8/CC88 and lacked arginine catabolic mobile element/copper and mercury resistance. Panton–Valentine leukocidin genes occurred in six isolates (four community-associated MRSA and two community-associated MSSA). WGS-based resistance prediction showed 91.7% categorical agreement with phenotypes. In the exploratory clinical analysis, prior antibiotic exposure, intensive care unit admission, and healthcare exposure score were associated with MRSA. Contemporary MRSA in this hospital is clonally concentrated, while MSSA is diverse. WGS identifies lineage-specific resistance and mobile element architectures, as well as one observation consistent with SCC mec excision, generating hypotheses for longitudinal surveillance rather than establishing a mechanism for MRSA decline. Clinical associations are secondary and exploratory. IMPORTANCE: Methicillin-resistant Staphylococcus aureus (MRSA) infections have declined in many hospitals, but cross-sectional clinical data alone cannot explain the genomic structure of the MRSA populations that remain. This study uses whole-genome sequencing to show that contemporary MRSA isolates from a Mexican university referral hospital are concentrated in a CC5 New York/Japan lineage, whereas methicillin-susceptible S. aureus (MSSA) isolates are genetically diverse. The analysis identifies lineage-specific resistance determinants, mobile genetic elements, prophage content, defense systems, and one CC5-MSSA isolate showing a pattern consistent with SCC mec excision. These findings provide a descriptive genomic baseline for longitudinal MRSA surveillance. The clinical risk-factor analysis is included as exploratory context, not as the primary evidence for the genomic conclusions.
- Open Access
- 26 April 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (2) , 214
In-Hospital Mortality Predictors and a Bayesian Weighted-Incidence Antibiogram in Infective Endocarditis: A Seven-Year Cohort Study from a Mexican Tertiary University Hospital
Background/Objectives: Infective endocarditis (IE) carries substantial mortality, particularly in middle-income settings where patient profiles and microbial ecology differ from those of cohorts used to derive international prognostic scores. Syndrome-specific, locally grounded decision aids for empirical therapy are also scarce. We aimed to identify predictors of in-hospital mortality, externally evaluate the RiskE and ICE scores, and construct a Bayesian weighted-incidence syndromic combination antibiogram (WISCA) for IE. Methods: We conducted a retrospective cohort study of consecutive adults with definite or possible IE admitted between January 2019 and January 2026. Candidate predictors were screened in two phases, and a clinically specified model was estimated with maximum-likelihood and Firth penalization, with 1000-replicate bootstrap optimism correction. Calibration was assessed with bootstrap calibration plots and the Hosmer–Lemeshow test. Discrimination was compared against RiskE and ICE using DeLong’s test and reclassification metrics. For empirical coverage, we built a WISCA using identified pathogens, reporting both non-Bayesian bootstrap estimates and Bayesian hierarchical partial-pooling estimates with species- and antibiotic-level random intercepts; analyses were also stratified by IE type. Results: In-hospital mortality was 22.9% in a young cohort (median 37 years) characterized by high hemodialysis prevalence (47.4%), substantial right-sided IE (46.4%), and Staphylococcus aureus predominance (32%) with no methicillin-resistant isolates. Vasopressor-requiring shock (Firth OR 9.23, 95% CI 2.40–40.61) and acute heart failure (OR 10.01, 95% CI 2.78–41.07) were the strongest predictors; the final model achieved an AUC of 0.922 (optimism-corrected 0.908), significantly outperforming RiskE (0.598) and ICE (0.632). The Bayesian WISCA identified multiple carbapenem-sparing and anti-MRSA–sparing regimens with adequate coverage (≥80%), particularly for community-acquired IE, supporting stewardship-oriented empirical selection. Coverage was consistently lower in healthcare-associated IE. Conclusions: A parsimonious three-variable model provided strong, locally valid mortality prediction in this hemodialysis-predominant, MRSA-free cohort, substantially outperforming European-derived scores. External validation in independent cohorts is required before clinical adoption. The Bayesian WISCA demonstrated that adequate empirical coverage is achievable without routine broad-spectrum agents, offering institution-specific guidance for stewardship-compatible regimen selection; multicenter validation is warranted.
- 26 April 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (2) , 214
Open AccessIn-Hospital Mortality Predictors and a Bayesian Weighted-Incidence Antibiogram in Infective Endocarditis: A Seven-Year Cohort Study from a Mexican Tertiary University Hospital
Background/Objectives: Infective endocarditis (IE) carries substantial mortality, particularly in middle-income settings where patient profiles and microbial ecology differ from those of cohorts used to derive international prognostic scores. Syndrome-specific, locally grounded decision aids for empirical therapy are also scarce. We aimed to identify predictors of in-hospital mortality, externally evaluate the RiskE and ICE scores, and construct a Bayesian weighted-incidence syndromic combination antibiogram (WISCA) for IE. Methods: We conducted a retrospective cohort study of consecutive adults with definite or possible IE admitted between January 2019 and January 2026. Candidate predictors were screened in two phases, and a clinically specified model was estimated with maximum-likelihood and Firth penalization, with 1000-replicate bootstrap optimism correction. Calibration was assessed with bootstrap calibration plots and the Hosmer–Lemeshow test. Discrimination was compared against RiskE and ICE using DeLong’s test and reclassification metrics. For empirical coverage, we built a WISCA using identified pathogens, reporting both non-Bayesian bootstrap estimates and Bayesian hierarchical partial-pooling estimates with species- and antibiotic-level random intercepts; analyses were also stratified by IE type. Results: In-hospital mortality was 22.9% in a young cohort (median 37 years) characterized by high hemodialysis prevalence (47.4%), substantial right-sided IE (46.4%), and Staphylococcus aureus predominance (32%) with no methicillin-resistant isolates. Vasopressor-requiring shock (Firth OR 9.23, 95% CI 2.40–40.61) and acute heart failure (OR 10.01, 95% CI 2.78–41.07) were the strongest predictors; the final model achieved an AUC of 0.922 (optimism-corrected 0.908), significantly outperforming RiskE (0.598) and ICE (0.632). The Bayesian WISCA identified multiple carbapenem-sparing and anti-MRSA–sparing regimens with adequate coverage (≥80%), particularly for community-acquired IE, supporting stewardship-oriented empirical selection. Coverage was consistently lower in healthcare-associated IE. Conclusions: A parsimonious three-variable model provided strong, locally valid mortality prediction in this hemodialysis-predominant, MRSA-free cohort, substantially outperforming European-derived scores. External validation in independent cohorts is required before clinical adoption. The Bayesian WISCA demonstrated that adequate empirical coverage is achievable without routine broad-spectrum agents, offering institution-specific guidance for stewardship-compatible regimen selection; multicenter validation is warranted.
- Open Access
- 24 April 2026
- Published by MDPI AG in Infectious Disease Reports
- Vol. 18 (3) , 39
Spontaneous Pneumomediastinum, Subcutaneous Emphysema, and Pneumoperitoneum in RT-PCR-Confirmed Measles: A Pediatric Case Report
Measles remains a major global public health challenge as declining vaccination coverage fuels outbreaks worldwide. Although pneumonia is the most recognized respiratory complication, spontaneous air leak syndrome—including pneumomediastinum, subcutaneous emphysema, and pneumoperitoneum—is rarely documented. We report the case of a 9-year-old previously healthy girl with no documented measles–rubella vaccination who presented with fever, maculopapular exanthem, Koplik spots, and persistent cough. Measles was confirmed by both immunoglobulin M enzyme-linked immunosorbent assay and real-time reverse transcription polymerase chain reaction. She developed sudden cervicothoracic swelling and chest pain. Chest radiography revealed pneumomediastinum and subcutaneous emphysema; computed tomography confirmed extensive air leak including pneumoperitoneum. Flexible bronchoscopy and upper gastrointestinal endoscopy excluded structural airway and esophageal injury. Laboratory evaluation revealed elevated hepatic transaminases, gamma-glutamyl transferase, lactate dehydrogenase, and D-dimer. Conservative management with high-flow supplemental oxygen and clinical surveillance led to progressive resolution. The patient was discharged on hospital day three, asymptomatic and breathing room air. This case highlights the spectrum of air leak complications in measles and supports conservative management in hemodynamically stable pediatric patients when structural injury has been excluded.
- 24 April 2026
- Published by MDPI AG in Infectious Disease Reports
- Vol. 18 (3) , 39
Open AccessSpontaneous Pneumomediastinum, Subcutaneous Emphysema, and Pneumoperitoneum in RT-PCR-Confirmed Measles: A Pediatric Case Report
Measles remains a major global public health challenge as declining vaccination coverage fuels outbreaks worldwide. Although pneumonia is the most recognized respiratory complication, spontaneous air leak syndrome—including pneumomediastinum, subcutaneous emphysema, and pneumoperitoneum—is rarely documented. We report the case of a 9-year-old previously healthy girl with no documented measles–rubella vaccination who presented with fever, maculopapular exanthem, Koplik spots, and persistent cough. Measles was confirmed by both immunoglobulin M enzyme-linked immunosorbent assay and real-time reverse transcription polymerase chain reaction. She developed sudden cervicothoracic swelling and chest pain. Chest radiography revealed pneumomediastinum and subcutaneous emphysema; computed tomography confirmed extensive air leak including pneumoperitoneum. Flexible bronchoscopy and upper gastrointestinal endoscopy excluded structural airway and esophageal injury. Laboratory evaluation revealed elevated hepatic transaminases, gamma-glutamyl transferase, lactate dehydrogenase, and D-dimer. Conservative management with high-flow supplemental oxygen and clinical surveillance led to progressive resolution. The patient was discharged on hospital day three, asymptomatic and breathing room air. This case highlights the spectrum of air leak complications in measles and supports conservative management in hemodynamically stable pediatric patients when structural injury has been excluded.
- Open Access
- 31 March 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (7) , 890
Healthcare Deserts and Avoidable Mortality in Mexico: A Municipal-Level Ecological Analysis of Health System Resources, Social Deprivation, and Preventable Deaths, 2015–2024
Background/Objectives: Avoidable mortality—deaths before age 75 from preventable or treatable causes—is a key indicator of health system performance. In Mexico, nearly two-thirds of municipalities lack hospital beds, yet no study has examined the municipal-level association between healthcare infrastructure and avoidable mortality. This study assessed whether healthcare desert status is independently associated with avoidable mortality after adjusting for social deprivation. Methods: This ecological study analyzed 1891 Mexican municipalities (population ≥ 1000) over 2015–2024. Avoidable deaths were classified per OECD/Eurostat criteria (January 2022 revision). Healthcare desert status was defined by municipal hospital bed availability from 2019 facility data. Negative binomial mixed-effects regression estimated incidence-rate ratios (IRRs) adjusted for social deprivation, age structure, and state-level heterogeneity. Interrupted time-series analysis quantified pandemic disruption. Results: Of 4,960,244 deaths under 75 years, 81.2% were avoidable. Of 1891 municipalities, 1187 (62.8%) lacked hospital beds (healthcare deserts). Desert municipalities had 42.5% higher avoidable mortality (IRR = 1.425; 95% CI: 1.370–1.482; pre-pandemic 2015–2019), which attenuated to 1.353 after age-structure adjustment. Each standard-deviation increase in hospital beds (1 SD ≈ 2.2 beds per 1000) was associated with 7.9% lower mortality (IRR = 0.921). Avoidable mortality exhibited strong spatial clustering (Moran’s I = 0.382) in southern Mexico. By 2024, the desert–adequate mortality gap had widened by approximately five fold (from 12 to 69 per 100,000 population). Conclusions: Healthcare deserts are independently associated with substantially higher avoidable mortality in Mexico. The COVID-19 pandemic durably amplified pre-existing disparities associated with healthcare infrastructure deficits. Targeted hospital expansion in underserved municipalities is urgently needed, alongside investment in social determinants of health.- 31 March 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (7) , 890
Open AccessHealthcare Deserts and Avoidable Mortality in Mexico: A Municipal-Level Ecological Analysis of Health System Resources, Social Deprivation, and Preventable Deaths, 2015–2024
Background/Objectives: Avoidable mortality—deaths before age 75 from preventable or treatable causes—is a key indicator of health system performance. In Mexico, nearly two-thirds of municipalities lack hospital beds, yet no study has examined the municipal-level association between healthcare infrastructure and avoidable mortality. This study assessed whether healthcare desert status is independently associated with avoidable mortality after adjusting for social deprivation. Methods: This ecological study analyzed 1891 Mexican municipalities (population ≥ 1000) over 2015–2024. Avoidable deaths were classified per OECD/Eurostat criteria (January 2022 revision). Healthcare desert status was defined by municipal hospital bed availability from 2019 facility data. Negative binomial mixed-effects regression estimated incidence-rate ratios (IRRs) adjusted for social deprivation, age structure, and state-level heterogeneity. Interrupted time-series analysis quantified pandemic disruption. Results: Of 4,960,244 deaths under 75 years, 81.2% were avoidable. Of 1891 municipalities, 1187 (62.8%) lacked hospital beds (healthcare deserts). Desert municipalities had 42.5% higher avoidable mortality (IRR = 1.425; 95% CI: 1.370–1.482; pre-pandemic 2015–2019), which attenuated to 1.353 after age-structure adjustment. Each standard-deviation increase in hospital beds (1 SD ≈ 2.2 beds per 1000) was associated with 7.9% lower mortality (IRR = 0.921). Avoidable mortality exhibited strong spatial clustering (Moran’s I = 0.382) in southern Mexico. By 2024, the desert–adequate mortality gap had widened by approximately five fold (from 12 to 69 per 100,000 population). Conclusions: Healthcare deserts are independently associated with substantially higher avoidable mortality in Mexico. The COVID-19 pandemic durably amplified pre-existing disparities associated with healthcare infrastructure deficits. Targeted hospital expansion in underserved municipalities is urgently needed, alongside investment in social determinants of health. - Open Access
- 9 March 2026
- Published by MDPI AG in Preprints.org
Spontaneous Pneumomediastinum, Subcutaneous Emphysema, and Pneumoperitoneum in RT-PCR-Confirmed Measles: A Pediatric Case Report
Measles remains a major global public health challenge as declining vaccination coverage fuels outbreaks worldwide. Although pneumonia is the most recognized respiratory complication, spontaneous air leak syndrome—including pneumomediastinum, subcutaneous emphysema, and pneumoperitoneum—is rarely documented. We report the case of a 9-year-old previously healthy girl with no documented measles–rubella vaccination who presented with fever, maculopapular exanthem, Koplik spots, and persistent cough. Measles was confirmed by both immunoglobulin M enzyme-linked immunosorbent assay and real-time reverse transcription polymerase chain reaction. She developed sudden cervicothoracic swelling and chest pain. Chest radiography revealed pneumomediastinum and subcutaneous emphysema; computed tomography confirmed extensive air leak including left pneumothorax and pneumoperitoneum. Flexible bronchoscopy and upper gastrointestinal endoscopy excluded structural airway and esophageal injury. Laboratory evaluation revealed elevated hepatic transaminases, gamma-glutamyl transferase, lactate dehydrogenase, and D-dimer. Conservative management with high-flow supplemental oxygen and clinical surveillance led to progressive resolution. The patient was discharged on hospital day three, asymptomatic and breathing room air. This case highlights the spectrum of air leak complications in measles and supports conservative management in hemodynamically stable pediatric patients when structural injury has been excluded.
- 9 March 2026
- Published by MDPI AG in Preprints.org
Open AccessSpontaneous Pneumomediastinum, Subcutaneous Emphysema, and Pneumoperitoneum in RT-PCR-Confirmed Measles: A Pediatric Case Report
Measles remains a major global public health challenge as declining vaccination coverage fuels outbreaks worldwide. Although pneumonia is the most recognized respiratory complication, spontaneous air leak syndrome—including pneumomediastinum, subcutaneous emphysema, and pneumoperitoneum—is rarely documented. We report the case of a 9-year-old previously healthy girl with no documented measles–rubella vaccination who presented with fever, maculopapular exanthem, Koplik spots, and persistent cough. Measles was confirmed by both immunoglobulin M enzyme-linked immunosorbent assay and real-time reverse transcription polymerase chain reaction. She developed sudden cervicothoracic swelling and chest pain. Chest radiography revealed pneumomediastinum and subcutaneous emphysema; computed tomography confirmed extensive air leak including left pneumothorax and pneumoperitoneum. Flexible bronchoscopy and upper gastrointestinal endoscopy excluded structural airway and esophageal injury. Laboratory evaluation revealed elevated hepatic transaminases, gamma-glutamyl transferase, lactate dehydrogenase, and D-dimer. Conservative management with high-flow supplemental oxygen and clinical surveillance led to progressive resolution. The patient was discharged on hospital day three, asymptomatic and breathing room air. This case highlights the spectrum of air leak complications in measles and supports conservative management in hemodynamically stable pediatric patients when structural injury has been excluded.
- Open Access
- 27 February 2026
- Published by MDPI AG in Preprints.org
In-Hospital Mortality Predictors and a Bayesian Weighted-Incidence Antibiogram in Infective Endocarditis: A Seven-Year Cohort Study from a Referral University Hospital
Background/Objectives: Infective endocarditis (IE) carries substantial mortality, particularly in middle-income settings where patient profiles and microbial ecology differ from those of cohorts used to derive international prognostic scores. Syndrome-specific, locally grounded decision aids for empirical therapy are also scarce. We aimed to identify predictors of in-hospital mortality, externally evaluate the RiskE and ICE scores, and construct a Bayesian weighted-incidence syndromic combination antibiogram (WISCA) for IE. Methods: We conducted a retrospective cohort study of consecutive adults with definite or possible IE admitted between January 2019 and January 2026. Candidate predictors were screened in two phases and a clinically specified model was estimated with maximum-likelihood and Firth penalization, with 1000-replicate bootstrap optimism correction. Discrimination was compared against RiskE and ICE using DeLong’s test and reclassification metrics. For empirical coverage, we built a WISCA using identified pathogens, reporting both non-Bayesian bootstrap estimates and Bayesian hierarchical partial-pooling estimates with species- and antibiotic-level random intercepts; analyses were also stratified by IE type. Results: In-hospital mortality was 22.9%. Septic shock (Firth OR 9.23, 95% CI 2.40–40.61) and acute heart failure (OR 10.01, 95% CI 2.78–41.07) were the strongest independent predictors; the final model achieved an AUC of 0.922 (optimism-corrected 0.908) and outperformed RiskE (AUC 0.598) and ICE (AUC 0.632). Bayesian WISCA ranked vancomycin + gentamicin and meropenem + gentamicin highest (both 87.0%); several β-lactam–based combinations provided comparably high coverage without requiring routine carbapenems. Coverage was consistently higher for community-acquired than healthcare-associated IE. Conclusions: A simple variable model provided strong, locally valid mortality prediction and substantially outperformed international scores in this hemodialysis-predominant cohort. Bayesian WISCA offers stable, institution-specific empirical coverage estimates that can support stewardship-oriented regimen selection; multicenter validation is warranted.
- 27 February 2026
- Published by MDPI AG in Preprints.org
Open AccessIn-Hospital Mortality Predictors and a Bayesian Weighted-Incidence Antibiogram in Infective Endocarditis: A Seven-Year Cohort Study from a Referral University Hospital
Background/Objectives: Infective endocarditis (IE) carries substantial mortality, particularly in middle-income settings where patient profiles and microbial ecology differ from those of cohorts used to derive international prognostic scores. Syndrome-specific, locally grounded decision aids for empirical therapy are also scarce. We aimed to identify predictors of in-hospital mortality, externally evaluate the RiskE and ICE scores, and construct a Bayesian weighted-incidence syndromic combination antibiogram (WISCA) for IE. Methods: We conducted a retrospective cohort study of consecutive adults with definite or possible IE admitted between January 2019 and January 2026. Candidate predictors were screened in two phases and a clinically specified model was estimated with maximum-likelihood and Firth penalization, with 1000-replicate bootstrap optimism correction. Discrimination was compared against RiskE and ICE using DeLong’s test and reclassification metrics. For empirical coverage, we built a WISCA using identified pathogens, reporting both non-Bayesian bootstrap estimates and Bayesian hierarchical partial-pooling estimates with species- and antibiotic-level random intercepts; analyses were also stratified by IE type. Results: In-hospital mortality was 22.9%. Septic shock (Firth OR 9.23, 95% CI 2.40–40.61) and acute heart failure (OR 10.01, 95% CI 2.78–41.07) were the strongest independent predictors; the final model achieved an AUC of 0.922 (optimism-corrected 0.908) and outperformed RiskE (AUC 0.598) and ICE (AUC 0.632). Bayesian WISCA ranked vancomycin + gentamicin and meropenem + gentamicin highest (both 87.0%); several β-lactam–based combinations provided comparably high coverage without requiring routine carbapenems. Coverage was consistently higher for community-acquired than healthcare-associated IE. Conclusions: A simple variable model provided strong, locally valid mortality prediction and substantially outperformed international scores in this hemodialysis-predominant cohort. Bayesian WISCA offers stable, institution-specific empirical coverage estimates that can support stewardship-oriented regimen selection; multicenter validation is warranted.